Information was received from a healthcare professional (hcp) via a clinical study regarding a patient receiving fentanyl 2000 mcg for a total dose of 801.3913 mcg/day and bupivacaine 20 mg for a total dose of 8.01391 mg/day via an implantable pump.It was reported on (b)(6) 2020 the patient reported an episode of heat and pain at the pump pocket site, but has subsided.The patient reported that their pump seemed to have moved, and might have broken through some scar tissue/pump anchor site.There was no concerns today.Examination revealed there was no redness, no swelling, and no signs of infection.It was suggested to ice, use lidocaine, and can wear an abdominal binder.The outcome of the event was noted as ongoing.The clinical diagnosis was pain at the pump pocket.The etiology of the event indicated the relationship of the event to the device or therapy was possibly related and indicated the relationship of the event to the implant procedure was not related.The incisional site/device tract was pump pocket.The event date was (b)(6) 2020.No further complications were reported.
|